Avanza Fonder’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.1M Buy
94,495
+16,386
+21% +$1.6M 0.15% 125
2026
Q2
$8.08M Sell
78,109
-16,331
-17% -$1.46M 0.18% 107
2026
Q1
$6.78M Sell
94,440
-8,191
-8% -$631K 0.19% 110
2025
Q4
$8.14M Buy
102,631
+7,149
+7% +$564K 0.21% 91
2025
Q3
$7.2M Buy
95,482
+9,600
+11% +$658K 0.19% 94
2025
Q2
$5.92M Sell
85,882
-5,480
-6% -$359K 0.18% 104
2025
Q1
$6.22M Sell
91,362
-14,342
-14% -$858K 0.2% 96
2024
Q4
$4.75M Hold
105,704
– – 0.14% 124

Other funds holding CVS

Avanza Fonder's CVS Position: Q3 2026 in Review

Avanza Fonder increased its CVS Health (CVS) stake by 21% in Q3 2026, buying an estimated $1.6M and bringing the position to 94,495 shares worth $8.1M. The position accounts for 0.15% of the portfolio, ranked #125.

Avanza Fonder first reported a position in CVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.14M in Q4 2025. 1,994 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Avanza Fonder held 94,495 shares of CVS Health worth $8.1M as of Q3 2026.
  • Avanza Fonder bought 16,386 CVS Health shares in Q3 2026, an estimated $1.6M.
  • CVS Health made up 0.15% of Avanza Fonder's portfolio in Q3 2026, its #125 holding.
  • Avanza Fonder first reported a position in CVS Health in Q4 2024 and has held it in 8 quarters since.
  • Avanza Fonder's CVS Health position peaked at $8.14M in Q4 2025.
  • 1,994 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.